Shares of Futura Medical plc (LON:FUM – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1.01 and traded as low as GBX 0.35. Futura Medical shares last traded at GBX 0.36, with a volume of 3,408,925 shares trading hands.
Futura Medical Trading Down 3.5%
The company has a market capitalization of £2.08 million, a PE ratio of -0.13 and a beta of 0.02. The business’s 50-day simple moving average is GBX 0.60 and its 200-day simple moving average is GBX 1.01.
Futura Medical (LON:FUM – Get Free Report) last posted its earnings results on Wednesday, April 29th. The company reported GBX (2.78) earnings per share for the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. The firm had revenue of GBX 170 million for the quarter. Sell-side analysts forecast that Futura Medical plc will post 2.8486672 EPS for the current fiscal year.
Futura Medical Company Profile
Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.
Featured Articles
- Five stocks we like better than Futura Medical
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
